Beijing Tumor Hospital Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2018
NCT03676946
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beijing Tumor Hospital